A study finds EWSR1-ETS in 42% of cases via complex, loop-like rearrangements, rather than by simple reciprocal translocations.
Taking corticosteroids at the time of treatment initiation with PD-L1 inhibitors may lead to inferior outcomes in patients with non–small-cell lung cancer.
It may be possible to predict personalized tumor progression in CRC patient's liquid biopsy and mathematical modeling.
A study shows significant association between MTHFR C677T polymorphisms and risk of oral squamous cell carcinoma.
MRI-guided laser interstitial thermal therapy appears to be safe and effective for glioblastomas and may add an average of 2 months to life expectancy.
Outcomes for patients with HER2-positive breast cancer did not differ when treated with sequential chemotherapy plus trastuzumab compared with a concurrent approach.
Recent studies on CAR T-cell immunotherapy, and the recent approval of a new agent, add to evidence supporting the efficacy of these therapies.
A 17-gene signature derived from circulating tumor cells was found to correlate with response to therapy in patients with breast cancer.
The combination of pembrolizumab and a TLR9 agonist known as SD-101 showed promising activity in patients with unresectable or metastatic melanoma.
The number of nurse practitioners and physician assistants in oncology is growing, according to a new study.